Faculty Members

IMPORTANT NOTE: Virtual meeting time indicated in the scientific program is expressed as CET Time Zone. Please check time as per your timezone

Volkan Korten
Turkey
Opening Session
*Chair
Start Time
10:05
End Time
11:45
Hamdi Akan
Turkey
Emerging technologies and their applications in febrile neutropenia
*Chair
Start Time
10:30
End Time
11:30
Dafna Yahav
Israel
Ethics, clinical trials and febrile neutropenia
*Chair
Start Time
11:30
End Time
13:00
Tezer Kutluk
Update on selected issues in febrile neutropenia
*Chair
Start Time
14:00
End Time
15:00
Halis Akalın
Turkey
Industry Supported Session / Management of Invasive Fungal Infection in Febrile Neutropenic Patients with Case Presentations
*Moderator
Start Time
14:30
End Time
15:30
Murat Akova
Turkey
Introduction to the Symposium
Presentation
Start Time
End Time
Young Fellows’ Presentations
*Chair
Start Time
11:45
End Time
12:15
New ECIL-10 Guidelines: Bacterial infections and antimicrobial resistance
*Chair
Start Time
12:30
End Time
14:30
Young fellows’ presentations
*Chair
Start Time
18:00
End Time
18:30
New therapeutic modalities and infectious complications
*Chair
Start Time
18:30
End Time
19:30
Young fellows’ presentation
*Chair
Start Time
16:30
End Time
17:30
Rafael De La Camara
Spain
Introduction to the Symposium
Presentation
Start Time
End Time
New ECIL-10 Guidelines: CMV, COVID-19 and other viral respiratory infections
*Chair
Start Time
16:30
End Time
18:00
Eda Karadoğan
Young Fellows’ Presentations
Presentation
*A scoring system to predict resistance to ceftolozane/ tazobactam in respiratory isolates of P. aeruginosa
Start Time
End Time
Leyla Yumrukaya
Turkey
Young Fellows’ Presentations
Presentation
*Cost effectiveness of carbapenem treatment duration in febrile neutropenia in patients with haematological malignancies
Start Time
End Time
Gülçin Telli Dizman
Turkey
Young fellows’ presentations
Presentation
*Risk of infection in patients with hematological malignancies recieving CAR-T cell threapy: Systematic review and metanalysis
Start Time
End Time
Emre Kara
Young fellows’ presentations
Presentation
*Therapeutic drug monitoring of meropenem in adult inpatients: A single center, retrospective study
Start Time
End Time
Abdullah Tarık Aslan
Turkey
Opening Session
Presentation
*Non-infectious causes of febrile neutropenia
Start Time
08:05
End Time
09:45
Ömrüm Uzun
Turkey
Opening Session
Presentation
*Antimicrobial stewardship in febrile neutropenia
Start Time
08:05
End Time
09:45
Ben Teh
Australia
Opening Session
Presentation
*Standardised reporting of infection events in immunocompromised patients
Start Time
08:05
End Time
09:45
Francesco Bacelli
Italy
New ECIL-10 Guidelines: Bacterial infections and antimicrobial resistance
Presentation
*Epidemiology of antibacterial resistance
Start Time
10:30
End Time
12:30
Dionysos Neofytos
Switzerland
New ECIL-10 Guidelines: Bacterial infections and antimicrobial resistance
Presentation
*Non-culture based diagnostics in febrile neutropenia
Start Time
10:30
End Time
12:30
Dina Averbuch
Israel
New ECIL-10 Guidelines: Bacterial infections and antimicrobial resistance
Presentation
*Empirical antibacterial therapy and duration of treatment
Start Time
10:30
End Time
12:30
Yuri Vanbiervliet
Belgium
New ECIL-10 Guidelines: Bacterial infections and antimicrobial resistance
Presentation
*Targeted antibacterial therapy
Start Time
10:30
End Time
12:30
Özlem Tunçcan
Turkey
Industry Supported Session / Management of Invasive Fungal Infection in Febrile Neutropenic Patients with Case Presentations
Presentation
Start Time
12:30
End Time
13:30
Recep Tekin
Turkey
Industry Supported Session / Management of Invasive Fungal Infection in Febrile Neutropenic Patients with Case Presentations
Presentation
Start Time
12:30
End Time
13:30
Malgorzata Mikulska
Italy
New ECIL-10 Guidelines: C. difficile infections and antifungal prophylaxis
*Chair
Start Time
15:30
End Time
16:30
New ECIL-10 Guidelines: C. difficile infections and antifungal prophylaxis
Presentation
*C. difficile infections in hematologic malignancies
Start Time
13:30
End Time
14:30
Livio Pagano
Italy
New ECIL-10 Guidelines: C. difficile infections and antifungal prophylaxis
Presentation
*Update on antifungal prohylaxis
Start Time
13:30
End Time
14:30
Hans H. Hirsch
Switzerland
New ECIL-10 Guidelines: CMV, COVID-19 and other viral respiratory infections
Presentation
*Update on community-acquired respiratory viral infections
Start Time
14:30
End Time
16:00
Simone Cesaro
Italy
New ECIL-10 Guidelines: CMV, COVID-19 and other viral respiratory infections
Presentation
*Update on COVID-19
Start Time
14:30
End Time
16:00
Roy Fouad Chemaly
United States
New ECIL-10 Guidelines: CMV, COVID-19 and other viral respiratory infections
Presentation
*Update on CMV infections
Start Time
14:30
End Time
16:00
Erika Kampouri
Switzerland
New therapeutic modalities and infectious complications
Presentation
*CAR T-cell therapy related infections
Start Time
16:30
End Time
17:30
Steven A. Pergam
United States
New therapeutic modalities and infectious complications
Presentation
*Summary of NCNN 2024 Guidelines: Prevention and treatment of cancer related infections
Start Time
16:30
End Time
17:30
Gökhan Metan
Turkey
Emerging technologies and their applications in febrile neutropenia
Presentation
*Decision support systems in febrile neutropenia
Start Time
08:30
End Time
09:30
Industry Supported Session / New Strength in the Primary Treatment of IFI: Posagil
Presentation
Start Time
End Time
Muhammed Cihan Işık
Young fellows’ presentation
Presentation
*Impact of Aspergillus PCR on the management of invasive aspergillosis: A tertiary care hospital experience during the COVID-19 pandemic
Start Time
End Time
Emine Dinç
Turkey
Young fellows’ presentation
Presentation
*Coexistance of invasive pulmonary aspergillosis and nocardiosis in an immunosuppressed patient
Start Time
End Time
Nilüfer Aylin Öztürk
Young fellows’ presentation
Presentation
Start Time
End Time
Young fellows’ presentation
Presentation
*Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience
Start Time
End Time
Elif Aras
Young fellows’ presentation
Presentation
*The role of clinical pharmacist in the management of antibacterial prophylaxis in neutropenia patients with cancer
Start Time
End Time
Ahmet Görkem Er
Turkey
Emerging technologies and their applications in febrile neutropenia
Presentation
*The role of artifical intelligence in febrile neutropenia
Start Time
08:30
End Time
09:30
Euzebiusz Jamrozik
Australia
Ethics, clinical trials and febrile neutropenia
Presentation
*Duration of antimicrobial therapy in febrile neutropenia: Ethical concerns
Start Time
09:30
End Time
11:00
Asma Nasim
Pakistan
Ethics, clinical trials and febrile neutropenia
Presentation
*Reverse isolation in febrile neutropenia: Ethical dilemmas
Start Time
09:30
End Time
11:00
Elda Righi
United Kingdom
Ethics, clinical trials and febrile neutropenia
Presentation
*Incorporation ethics into infectious disease clinical practice guidelines
Start Time
09:30
End Time
11:00
Thomas Lehrnbecher
Germany
Update on selected issues in febrile neutropenia
Presentation
*Pediatric febrile neutropenia
Start Time
11:00
End Time
12:00
Jon Salmanton Garcia
Germany
Update on selected issues in febrile neutropenia
Presentation
*Vaccination in patients with hematological cancer and hematopoietic stem cel transplantation
Start Time
11:00
End Time
12:00
Sevtap Arıkan Akdağlı
Turkey
What is new in fungal infections
*Chair
Start Time
15:00
End Time
16:30
What is new in fungal infections
Presentation
*Climate change and fungal infections
Start Time
12:00
End Time
13:30
Matteo Bassetti
Italy
What is new in fungal infections
Presentation
*Fungal infections in the ICU
Start Time
12:00
End Time
13:30
Martin Hönigl
Austria
What is new in fungal infections
Presentation
*Update on new antifungals
Start Time
12:00
End Time
13:30